Formulation and Device Considerations for Subcutaneous Delivery

27 September 2022 09:40 - 10:15

  • Overview of subcutaneous delivery in the current market
  • Considerations when developing a target product profile for subcutaneous delivery
  • Identifying early challenges and opportunities in formulation and device development
  • Technology down selection and moving forward towards the target image

Steven Persak, Director, Device Development, Merck

William Forrest, Principal Scientist I Sterile Formulation Sciences, Merck